These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 22804353)
1. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD; Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353 [TBL] [Abstract][Full Text] [Related]
2. Alloimmunization in sickle cell anemia in the era of extended red cell typing. O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932 [TBL] [Abstract][Full Text] [Related]
3. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease. Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856 [TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization: lessons from sickle cell disease. Treml A; King KE Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994 [No Abstract] [Full Text] [Related]
5. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom. Mijovic A; Perera IG; Thein SL Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815 [No Abstract] [Full Text] [Related]
6. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Castro O; Sandler SG; Houston-Yu P; Rana S Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion. Jariwala K; Mishra K; Ghosh K Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372 [TBL] [Abstract][Full Text] [Related]
8. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582 [TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA Transfusion; 2014 Aug; 54(8):2034-44. PubMed ID: 24571485 [TBL] [Abstract][Full Text] [Related]
10. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [TBL] [Abstract][Full Text] [Related]
11. Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice. Breiki ASA; Kindi SA; Castilho L Immunohematology; 2024 Sep; 40(3):93-99. PubMed ID: 39373300 [TBL] [Abstract][Full Text] [Related]
12. Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units. Le Gallo M; Moutereau S; Gentil M; Pirenne F Transfus Clin Biol; 2024 Aug; 31(3):130-134. PubMed ID: 38462030 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia. Al-Asmari B; Baothman A; Almohammadi M; Aljuaid M; Jastaniah W J Pediatr Hematol Oncol; 2024 Jul; 46(5):e284-e289. PubMed ID: 38857199 [TBL] [Abstract][Full Text] [Related]
15. Transfusion therapy for sickle cell disease: a balancing act. Chou ST Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B; Padmanabhan S; Paley C; Chandrasekaran V Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [TBL] [Abstract][Full Text] [Related]
17. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization. Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200 [TBL] [Abstract][Full Text] [Related]
18. Alloimmunization in transfused patients with constitutional anemias in Norway. Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452 [TBL] [Abstract][Full Text] [Related]
20. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Vichinsky EP Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146 [No Abstract] [Full Text] [Related] [Next] [New Search]